T-Cypher Bio

We are a passionate, committed, friendly and diverse group of experts. We are led by a team of scientific and business leaders with a track record of developing successful biotechnology companies to benefit patients. Our proprietary platforms provide unique insight into T cell based immunity in both health and disease. These platforms not only give us tools to build highly innovative drugs, but also build immune system data sets of unprecedented size. We share a deep sense of duty to work with passion and develop our leading technologies for the benefit of patients.We are backed by leading, specialist, long-term investors who share our passion and who facilitate our path to delivering lifesaving therapeutics. Thomas is a serial entrepreneur, having founded several US and EU life-science companies including Torque Therapeutics, Nanovi A/S, and Monta Biosciences. Phil co-founded Borealis Ventures in 2002 and has led the firm’s healthcare investing from its inception. Prior to joining Medicxi, Shyam founded two early-stage biotechnology companies (Shyden Biotechnology and Cleavr Therapeutics).